BioSpace News Archive

PBS Biotech, a leading provider of single-use bioreactor systems and process development services, announces the successful attainment of the ISO 9001:2015 certification of its Quality Management System.

MolecuLight Inc. announces that its MolecuLight wound imaging platform is being prominently featured in several presentations and posters at the European Wound Management Association 2024 Annual Conference, being held from May 1 - 3, 2024 in London, United Kingdom.

G1 Therapeutics, Inc., a commercial-stage oncology company, provided a corporate and financial update for the first quarter ended March 31, 2024.

Bio-Techne Corporation reported its financial results for the third quarter ending March 31, 2024.

Immunic, Inc., a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, announced that the company will release its financial results for the first quarter ended March 31, 2024, including a corporate update, on Wednesday, May 8, 2024, before the opening of the U.S. financial markets.

Chimerix reported financial results for the first quarter ended March 31, 2024 and provided an operational update.

Amarin Corporation plc, provided an update on the Company’s business highlights and announced financial results for the quarter ended March 31, 2024.

Quest Diagnostics announced a multi-faceted collaboration designed to accelerate the adoption of digital and AI pathology innovations to improve quality, speed and efficiency in diagnosing cancer and other diseases.

Syndax Pharmaceuticals, a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced that it will report its first quarter 2024 financial results and provide a business update on Wednesday, May 8, 2024.

Amgen announced the presentation of new respiratory data at the American Thoracic Society 2024 International Conference taking place May 12-22 in San Diego.